1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 16,16-dimethylprostaglandin e2 in 3 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (16,16-dimethylprostaglandin e2) | Trials (16,16-dimethylprostaglandin e2) | Recent Studies (post-2010) (16,16-dimethylprostaglandin e2) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 542 | 22 | 14 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steel, G; Wallace, JL; Whittle, BJ | 1 |
| Chayvialle, JA; Cuber, JC; Minaire, Y; Mion, F | 1 |
| Davis, HD; Kumar, KS; Landauer, MR; Weiss, JF | 1 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 16,16-dimethylprostaglandin e2
| Article | Year |
|---|---|
Failure of prostaglandin E2 and its 16,16-dimethyl analogue to prevent the gastric mucosal damage induced by Paf.
Topics: 16,16-Dimethylprostaglandin E2; Administration, Oral; Animals; Blood Pressure; Capillary Permeability; Dinoprostone; Ethanol; Injections, Intravenous; Male; Platelet Activating Factor; Prostaglandins E; Prostaglandins E, Synthetic; Rats; Rats, Inbred Strains; Stomach Ulcer | 1987 |
Short term effects of indomethacin on rat small intestinal permeability. Role of eicosanoids and platelet activating factor.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Culture Techniques; Edetic Acid; Eicosanoids; Ileum; Indomethacin; Kinetics; Leukotriene B4; Leukotriene D4; Male; Permeability; Platelet Activating Factor; Rats; Rats, Wistar | 1994 |
Behavioral toxicity of selected radioprotectors.
Topics: 16,16-Dimethylprostaglandin E2; Adjuvants, Immunologic; Amifostine; Animals; Caffeine; Central Nervous System Stimulants; Cord Factors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucans; Interleukin-1; Leukotriene C4; Male; Mice; Motor Activity; Phospholipids; Platelet Activating Factor; Radiation-Protective Agents; Sulfhydryl Compounds | 1992 |